Calendar Black Diamond Therapeutics, Inc.

Equities

BDTX

US09203E1055

Market Closed - Nasdaq 01:30:00 27/04/2024 am IST 5-day change 1st Jan Change
5.89 USD +15.26% Intraday chart for Black Diamond Therapeutics, Inc. +11.98% +109.61%

Chart calendar Black Diamond Therapeutics, Inc.

00ecb55c7d3ffa811.kO_JLEK3hNOeAP6TwL-4Uel2w_zLlVQONdrKimXwvT0.vaqZHjKAxuPzNJXY8MbPMrom8ZeY2T5rf5T_4z-b8Qv_la1YdJrju6xNsw~dd7398e25f6713e6a65fb8df2979a310

Upcoming events on Black Diamond Therapeutics, Inc.

08/05/2024 Q1 2024 Earnings Release (Projected)
01/06/2024 07:30 pm American Society of Clinical Oncology Annual Meeting - Abstract: 2068
01/06/2024 07:30 pm American Society of Clinical Oncology Annual Meeting - Abstract: 2069
06/06/2024 06:30 pm Annual General Meeting
08/08/2024 Q2 2024 Earnings Release (Projected)
04/11/2024 Q3 2024 Earnings Release (Projected)
12/03/2025 Q4 2024 Earnings Release (Projected)

Past events on Black Diamond Therapeutics, Inc.

17/04/2024 Piper Sandler Spring Biopharma Symposium
16/04/2024 07:30 pm Stifel Virtual Targeted Oncology Days Conference
10/04/2024 05:30 pm Needham Healthcare Conference
08/04/2024 03:30 am American Association for Cancer Research Meeting - Abstract No - 1229
12/03/2024 05:30 pm Q4 2023 Earnings Release
06/03/2024 07:40 pm TD Cowen Health Care Conference - Panel
30/11/2023 03:00 am Piper Sandler Healthcare Conference
15/11/2023 12:55 am Stifel Healthcare Conference
06/11/2023 06:15 pm Q3 2023 Earnings Release
14/10/2023 10:00 pm AACR-NCI-EORTC International Conference - A Phase 1 Study to Assess BDTX
14/10/2023 10:00 pm AACR-NCI-EORTC International Conference - Phase 1 Study of BDTX
12/10/2023 10:00 pm AACR-NCI-EORTC International Conference - Preclinical Efficacy of BDTX
12/09/2023 08:30 pm H.C. Wainwright Global Investment Conference
12/09/2023 01:05 am Morgan Stanley Global Healthcare Conference
06/09/2023 Wells Fargo Healthcare Conference
11/08/2023 05:00 pm Q2 2023 Earnings Release
27/06/2023 05:30 pm BDTX-1535 Phase 1 Clinical Study Results Call
09/06/2023 10:15 pm Jefferies Global Healthcare Conference
16/05/2023 06:30 pm Annual General Meeting
09/05/2023 Q1 2023 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Million USD
Released
Forecast
Spread
-29,3
-27,0
-8.46%
-69,5
-71,5
2.77%
-127
-137
7.54%
-92,3
-93,0
0.73%
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-29,3
-27,2
-7.97%
-69,6
-69,1
-0.69%
-127
-138
7.8%
-92,8
-94,0
1.21%
-86,5
-90,2
4.18%

-95,8

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-35,3
-34,1
-3.27%
-67,3
-66,9
-0.54%
-126
-136
7.74%
-91,2
-92,6
1.59%
-82,4
-86,7
4.9%

-94,1

Net income
Million USD
Released
Forecast
Spread
-35,3
-34,1
-3.27%
-67,3
-67,0
-0.44%
-126
-136
7.87%
-91,2
-93,0
1.95%
-82,4
-87,2
5.4%

-93,8

EPS
USD
Released
Forecast
Spread
-17,0
-12,4
-36.69%
-2,05
-2,04
-0.32%
-3,47
-3,76
7.79%
-2,52
-2,56
1.37%
-1,88
-1,98
5.24%

-1,71

Announcement Date24/03/2025/03/2117/03/2209/03/2312/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00


0,00

EBITDA
Million USD
Released
Forecast
Spread
-26,0
-36,0
27.9%







































EBIT
Million USD
Released
Forecast
Spread
-26,1
-36,8
29.19%
-25,7
-27,6
6.83%
-23,2
-24,9
6.96%
-22,1
-23,3
5.14%
-21,9
-23,0
4.81%
-21,6
-22,3
3.48%
-20,0
-22,3
10.08%
-24,0
-22,3
-7.47%
-20,9
-24,6
15.33%

-22,9


-23,6


-24,2


-25,0


-33,0

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-25,9
-36,6
29.31%
-25,5
-27,5
7.25%
-22,9
-24,4
6.04%
-21,7
-23,0
6.01%
-21,1
-22,4
5.79%
-20,9
-21,7
3.8%
-19,2
-21,8
12.19%
-23,0
-22,2
-3.6%
-19,4
-23,7
17.98%

-22,6


-23,2


-23,8


-24,5


-33,0

Net income
Million USD
Released
Forecast
Spread
-25,9
-36,8
29.76%
-25,5
-27,4
6.97%
-22,9
-25,3
9.38%
-21,7
-23,2
6.79%
-21,1
-22,9
8.02%
-20,9
-22,0
4.99%
-19,2
-22,0
12.98%
-23,0
-22,0
-4.55%
-19,4
-24,1
19.57%

-22,4


-23,0


-23,7


-24,6


-33,0

EPS
USD
Released
Forecast
Spread
-0,71
-1,01
29.88%
-0,70
-0,75
6.89%
-0,63
-0,70
9.68%
-0,60
-0,64
6.25%
-0,59
-0,63
5.85%
-0,57
-0,61
6.17%
-0,52
-0,54
2.8%
-0,45
-0,49
7.53%
-0,34
-0,47
27.04%

-0,44


-0,43


-0,43


-0,41


-0,49

Announcement Date17/03/2211/05/2209/08/2208/11/2209/03/2309/05/2311/08/2306/11/2312/03/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BDTX Stock
  4. Calendar Black Diamond Therapeutics, Inc.